Wednesday, April 27.
6:30 pm – 9:30 pm.
$15 General Public / $10 Caritas Members.
Dr. Bonlie will speak on this fascinating topic and its profound affect on health and healing. He has been involved in full-time research and development in bio-magnetism for the past 26 years. His scientific theory on the action of magnetism on living tissue has been validated in numerous studies, making him a widely accepted authority in this field. He is past president of the North American Academy of Magnetic Therapy. Dr. Bonlie has been interviewed extensively on radio, TV, and webinars. This presentation will be of interest to anyone on a journey of wellness and healing and especially therapists, doctors, and practitioners involved in new and innovative approaches to supporting health.
Dean Bonlie D.D.S. graduated with honors from Loma Linda University in 1962. Since then, his occupational journey has been varied and colourful. During the last twenty-six years he has found his real fulfillment in the study of magnetism as it relates to health. He has devoted all his energy and focus in this arena. His scientific theory on the effect of magnetism on living tissue has made him a widely accepted authority in this field. He is now recognized as an expert researcher, inventor, consultant, and lecturer on biomagnetism. In the past, Dr. Bonlie has taught courses in magnetic treatment for the Integrative Medicine post-doctoral degree offered by Capital University in Washington, DC., and developed a course in magnetic therapy for the International College of Naturopathy in California.
Initially, his research led to the design and production of the Magnetico Sleep Pad which is patented form of magnetic supplementation and the only device that correctly restores the Earth-type magnetic field. Later – advancing the technology further he then developed and patented a high strength, clinical treatment magnet called the Magnetic Molecular Energizer (MME). The MME os now operational in several Advanced Magnetic Research Institute clinics in the US. Phase III studies for FDA approval are now finished. The primary types of conditions being treated are neurological and orthopedic, but pilot studies are showing potential cardiology applications as well. This high-energy treatment is safe and non-invasive while achieving results previously not thought possible.